18
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Expression of Substance P (NK1) Receptor mRNA in Human Nose

Pages 717-722 | Published online: 08 Jul 2009

References

  • Guard S, Watson S. Tachykinin receptor sub-types:classification and membrane signaling mecha-nisms. Neurochem Int 1991; 18: 149–65.
  • Barnes PJ, Baraniuk IN, Belvisi MG. Neuropeptides in the respiratory tract. Am Rev Respir Dis 1991; 144: 1391–9.
  • Baraniuk JK, Lundgren JD, Mullol J, Okayama M. Merida M, Kaliner MA. Substance P and neu-rokinin A in human nasal mucosa. Am J Respir Cell Mol Biol 1991; 4: 228–36.
  • Mosimann BL, White MV, Hohman RJ, Goldrich MS, Kaulbach HC, Kaliner MA. Allergens, IgE, me-diators, inflammatory mechanisms: substance P, cal-citonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol 1993; 92: 95–104.
  • Holzer P. Capsaicin: cellular targets, mechanisms of action and selectivity for thin sensory neurons. Phar-macol Rev 1991; 43: 143–201.
  • Stjärne P, Lundblad L, Anggard A, Lundberg JM. Local capsaicin treatment of the nasal mucosa re-duces symptoms in patients with nonallergic nasal hyperreactivity. Am J Rhinol 1991; 5: 145–51.
  • Gerard NP, Garraway LA, Eddy RL. Human sub-stance P receptor (NKi): organization of the gene, chromosome localization, and functional expression of cDNA clones. Biochemistry 1991; 30: 10640–6.
  • Gerard NP, Eddy RL, Shows TB, Gerard C. The human neurokinin A (Substance K) receptor. J Biol Chem 1990; 265: 20455–62.
  • Buell G, Schulz MF, Arkinstall SJ, et al. Molecular characterisation, expression and localisation of hu-man neurokinin-3 receptor. FEBS Lett 1992; 299: 90–5.
  • Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phe-nol-chloroform extraction. Anal Biochem 1987; 162: 156–9.
  • Birk PE, Grimm PC. Rapid nonradioactive in situ hybridization for interleukin-2 mRNA with ribo-probes generated using the polymerase chain reac-tion. J Immunol Methods 1994; 167: 83–9.
  • Carstairs JR, Barnes PJ. Autoradiographic mapping of substance P receptors in lung. Eur J Pharmacol 1986; 127: 295–6.
  • Fischer A, Kummer W, Couraud J-Y, Adler D, Branscheid D, Heym C. Immunohistochemical local-ization of receptors for vasoactive intestinal peptide and substance P in human trachea. Lab Invest 1992; 67: 387–93.
  • Couraud J-Y, Maillet S, Grassi J, Frobert Y, Pradelles P. Characterization and properities of anti-substance P anti-idiotypic antibodies. Methods Enzy-mol 1989; 178: 275–300.
  • Bai TR, Zhou D, Weir T, et al. Substance P (NKI)-and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases. Am J Physiol 1995; 269: L309–17.
  • Mullol J, Rieves RD, Baraniuk IN, et al. The ef-fects of neuropeptides on mucous glycoprotein secre-tion from human nasal mucosa in vitro. Neuropeptides 1992; 21: 231–8.
  • Al-Bazzaz FJ, Kelsey JG, Kaage WD. Substance P stimulation of chloride secretion by canine tracheal mucosa. Am Rev Respir Dis 1985; 131: 86–9.
  • Kuo HP, Rohde JA, Tokuyama K, Barnes PJ, Rogers DF. Capsaicin and sensory neuropeptide stimulation of goblet cell secretion in guinea-pig tra-chea. J Physiol 1990; 431: 629–41.
  • Kondo M, Tamaoki J, Takizawa T. Neutral en-dopeptidase inhibitor potentiates the tachykinin-in-duced increase in ciliary beat frequency in rabbit trachea. Am Rev Respir Dis 1990; 142: 403–6.
  • Miadonna A, Tedeschi A, Leggieri E, et al. Activity of substance P on human skin and nasal airways. Ann Allergy 1988; 61: 220–3.
  • Geppetti P, Fusco BM, Marabini S, Maggi CA, Fani-ullacci M, Sicuteri F. Secretion, pain and sneez-ing induced by application of capsaicin to the nasal mucosa in man. Br J Pharmacol 1988; 93: 509–14.
  • Petersson G, McCaffirey TV, Malm L. Substance P and nasal secretion in dog, and rat and man. Ann Allergy 1989; 62: 410–4.
  • Baraniuk JN, Ohkubo K, Kwon OJ, et al. Localization of neutral endopeptidase mRNA in human nasal mu-cosa. J Appl Physiol 1993; 74: 272–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.